BIRC5 and breast carcinoma: To establish whether these truncated versions of survivin could inhibit cell growth, the cell-inhibitory effect of TAT-BIR(T34A), TAT-CC(T117A), and TAT-Survivin(T34/117A) were determined by MTT assay on human breast carcinoma cell lines Bcap-37.